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Abstract.  The enveloped alphavirus  Semliki Forest 
virus (SFV) infects cells via a membrane fusion reac- 
tion triggered by low pH.  For fusion to occur choles- 
terol is required in the target membrane,  as demon- 
strated both in in vitro fusion assays and in vivo for 
virus infection of a host cell. In this paper we exam- 
ine the role of cholesterol in postfusion events in the 
SFV life cycle. Cholesterol-depleted insect cells were 
transfected with SFV RNA or infected at very high 
multiplicities to circumvent the fusion block caused by 
the absence of cholesterol.  Under these conditions, the 
viral spike proteins were synthesized and transported 
to the site of p62 cleavage with normal kinetics.  Sur- 
prisingly,  the subsequent exit of virus particles was 
dramatically  slowed compared to cholesterol-contain- 
ing cells.  The inhibition of virus production could be 
reversed by the addition of cholesterol to depleted 
cells. In contrast to results with SFV, no cholesterol 
requirement for virus exit was observed for the 
production of either the unrelated vesicular stomatitis 
virus or a cholesterol-independent SFV fusion mutant. 
Thus,  cholesterol was only critical in the exit pathway 
of viruses that also require cholesterol for fusion. 
These results demonstrate a  specific and unexpected 
lipid requirement in virus exit,  and suggest that in ad- 
dition to its role in fusion, cholesterol is involved in 
the assembly or budding of SFV. 
T 
HE entry of viruses into their host cells is a key step in 
the virus infection pathway. The enveloped alphavirus, 
Semliki  Forest virus (SFV)L infects cells via recep- 
tor-mediated endocytosis, followed by a membrane fusion 
reaction triggered by the acid pH in endosomes (15). This po- 
tent low pH-induced membrane fusion activity has been ex- 
tensively characterized both in infected cells and by in vitro 
fusion assays. Fusion is mediated by the viral spike protein, 
which contains two transmembrane glycopolypeptides, E1 
(50,786 D) and E2 (51,855 D), and a peripheral glycopoly- 
peptide, E3 (11,369 D) (reviewed in references  39 and 41). 
Low pH has been shown to cause a number of conforma- 
tional changes in the viral spike protein (1, 15-17, 22, 24, 30, 
47--49). In addition  to the low pH requirement for fusion, 
cholesterol has been shown to play a key role in the fusion 
reaction.  Analysis of SFV-liposome interactions  showed that 
fusion requires  cholesterol  in  the target  membrane,  with 
maximal  effects occurring at a sterol to phospholipid ratio 
of 0.5 (1, 50). Other sterols containing  a 3/3-hydroxyl group 
can substitute for cholesterol, even if they do not produce the 
same effects as cholesterol on lipid bilayer fluidity, phospho- 
lipid  condensation,  and hydrocarbon chain  ordering  (18). 
Thus, cholesterol does not seem to be acting as a membrane 
fluidizing  agent.  Instead,  the role of cholesterol in fusion 
1. Abbreviations  used in this paper: HIFCS, heat-inactivated FCS; LDL, 
low-density lipoprotein; SFV, Semliki Forest virus; VSV, vesicular stomati- 
tis virus. 
may involve a direct interaction  with the SFV spike protein, 
since a proteolytically truncated form of the E1 subunit re- 
quires both low pH and a 3/$-hydroxysterol in order to un- 
dergo its conformational  change at acidic pH (16, 17). 
In previous work, we exploited the observation that insect 
cells are cholesterol auxotrophs  (3, 29), and can be main- 
tained virtually devoid of cholesterol by growth in culture 
medium containing  low-density lipoprotein (LDL)-depleted 
serum (40).  Such cholesterol-deficient  insect cells are un- 
changed in phospholipid composition, do not synthesize any 
replacement sterol,  and unlike  mammalian  cells show no 
deleterious  effects  from  sterol  depletion  (40).  Using  the 
C6/36 mosquito cell line as a host, we compared all of the 
steps of the virus infection pathway under control and sterol- 
depleted conditions  (35).  The cholesterol-depleted cells are 
unaltered in their ability to bind, internaliTe, and acidify vi- 
rus,  but are blocked in SFV fusion and subsequent virus 
replication.  In contrast,  the depleted cells are readily in- 
fected by the cholesterol-independent  vesicular stomatitis vi- 
rus (VSV), which also enters cells via endocytosis and low 
pH-triggered fusion (25).  The block in  SFV infection  is 
specifically  reversed  by repletion  with a 3/~-hydroxysterol. 
Although these experiments  show that SFV entry into the 
cell requires cholesterol, there are several important viral 
replication  events after the fusion step that may also have a 
cholesterol requirement.  For example,  viral RNA replica- 
tion is known to occur on membranes (7), and synthesis of 
virus RNA requires continuous cellular phospbolipid syn- 
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has not been determined. Sterol could also play a role in the 
transport and function of the transmembrane spike protein, 
or in correct virus assembly and budding. Here we have ana- 
lyzed the cholesterol requirements in these postfusion events 
in the SFV life cycle, using RNA transfection or high mul- 
tiplicity infection to express the SFV genome in cholesterol- 
depleted cells. Our results indicate a striking and unexpected 
requirement for cholesterol in the exit pathway of SFV. 
Materials and Methods 
Virus and Cells 
C6/36 cells, a clonal celt line derived from Aedes albopictus (13),  were 
grown at 28°C in DME containing 100 U/nil penicillin and streptomycin 
and 10% heat-inactivated FCS (HIFCS). Cholesterol-depleted C6/36 cells 
were maintained at 28°C in DME and 10%  delipidated H1FCS as previ- 
ously described (35), and all incubations of  C6/36 cells were at 28°C unless 
otherwise noted. After an adaptation period without cholesterol, the cells 
appeared  morphologically normal,  although they grew somewhat more 
slowly. The depleted cells have currently been passaged for more than a year 
under %terol-free" conditions. These culture conditions reduce both free 
and esterified cholesterol to levels <2% those of control cells (35, 40). 
BHK-21 cells were cultured at 37°C in DME containing 5% FCS, 100 
U/rnl penicillin and streptomycin, and 10%  tryptose phosphate broth. 
The virus stocks used in these experiments were a plaque-purified SFV 
wild type isolate (19), the Indiana strain of VSV, and srf-1, an SFV mutant 
selected to be cholesterol-independent. Stocks of wt SFV or VSV were 
grown and titered on BHK-21 cells. Srf-1 (for s..terol requirement in fusion) 
was selected by serial passage on C6/36 cells without cholesterol, and iso- 
lated by limiting dilution on these cells. It is one of three such mutants 
whose isolation and characterization will be described in detail elsewhere 
(Phalen, T., M. T. Marquardt, and M. Kielian, manuscript in preparation). 
The tiler of sr__f-1 was determined by infectious center assay on choles- 
terol-depleted C6/36 cells. 
Expression of Virus in Control and 
Cholesterol-depleted Cells 
Two  methods  were  used  to  express the  SFV  genome  in  control  and 
cholesterol-depleted C6/36 cells. 
RNA Transfection, Viral RNA was isolated by phenol-chloroform and 
SDS extraction (31) of purified SFV. RNA transfection was performed in 
Opti-MEM, a serum-free medium (Life Technologies, Grand Island, NY), 
and used either 6 ttg Lipofectin, a cationic liposome mixture (Life Technol- 
ogies), and 1 #g RNA/35 mm dish of cells, or 1.5/~g lipofeetin and 100 
ng RNA/well of a 24-well plate. After a  1-h transfection period, cells were 
incubated in Opti-MEM containing 0.2 % BSA (Opti-MEM/BSA) and 100 
U/ml penicillin and streptomycin. 
Prebinding and Infection  with SFV.  High multiplicity infection was 
used to express SFV in depleted ceils. Virus at multiplicities ranging from 
100-2,000 pfu/cell was bound to depleted cells in RPMI 1640 medium con- 
taining 0.2% BSA and 10 mM Hepes, pH 6.8, without bicarbonate. Binding 
was performed on ice with shaking for 60-90 min. The inoculum was aspi- 
rated and the cells were cultured in Opti-MEM/BSA at 28°C. This protocol 
was used for all of the SFV infections of depleted cells. SFV infection of 
cholesterol-containing cells,  or  infection of either  cell  type  with  srf-1 
followed a similar prebinding procedure, but using the indicated lower mul- 
tiplicities. Infection of either cell type with VSV was performed at 28°C 
without prebinding as previously described (35). 
Quantitation of  SFV Expression after 
Infection or Transfection 
Virus infection experiments were performed with cells plated on 12-mm 
round coverslips in 24-well plates. Control or depleted cells were infected 
with serial dilutions of SFV as described above.  2 h after infection, the 
medium was replaced with Opti-MEM/BSA plus 15 mM NI-I4CI to prevent 
secondary infection, and cells were incubated overnight. For RNA transfec- 
tion, both control and depleted cells in 35-ram plates containing 22-mm 
coverslips were transfected as described above, and then incubated for 6 h 
in 2 mls Opti-MEM/BSA. All cells were then fixed with methanol and ana- 
lyzed for spike protein expression by staining with a rabbit anti-spike anti- 
body and a fluorescein-labeled second antibody (17). Cells expressing the 
spike protein were quantitated by fluorescence microscopy. The 6-h incuba- 
tion period was chosen as a time when both cell types showed abundant ex- 
pression of SFV spike protein, but before the infection spread to adjacent 
cells. 
To evaluate delivery of the spike protein to the cell surface, control and 
depleted cells were transfected as above in 24-well trays containing 12-mm 
coverslips. After overnight incubation, cells were fixed with paraformalde- 
hyde  under  non-permeabilizing conditions and  stained  with previously 
characterized mAbs against the E1 or E2 spike protein subunits (17). 
Production of  Infectious SFV by Transfected Cells 
Both control and depleted cells in 35-ram plates containing 22-mm cover- 
slips were transfected as described above, and then incubated for 6 or 8 h 
in  2  mls  Opti-MEM/BSA.  Media  were collected from the transfected 
dishes, and cell debris pelleted by centrifugation at 10,000 rpm for 20-30 
rain in a Sorvall SS34 rotor (DuPont, Newton, CT) at 4°C. The media were 
then treated with 100 t~g/ml RNAse A for 30 rain at 37°C to remove residual 
virus RNA. Control experiments showed that this treatment did not reduce 
infectivity of virus particles, but degraded any SFV RNA remaining from 
the transfection. The virus in the supernatant was quantitated by plaque as- 
say on BHK-21 cells (19). Transfection efficiency was assessed in each ex- 
periment using immunofluorescence as described above. 
Production of  Radiolabeled Virus by Infected Cells 
Cells were infected as described above by either prebinding on ice or 28°C 
incubation with the indicated multiplicities of SFV, VSV, or srf-1.  After 
infection, cells were incubated for 18-22 h to establish viral expression. 
Cells were then preincubated for 15-30 min in methionine-free medium, 
and labeled for 15-30 rain with 20-200 #Ci/ml [35S]methionine  (Trans- 
label;  New England Nuclear,  Wilmington, DE) as previously described 
(17).  The concentration of label was increased about two- to fourfold for 
depleted cells infected with wt SFV to normalize the level of spike protein 
expression.  Cells  were  chased  for  various  periods  of  time  in  Opti- 
MEM/BSA plus 10× cold methionine (17). At the time of  harvest, the chase 
medium was removed and the cells were lysed as previously described (17). 
Protease  inhibitors (0.5  mM  PMSE  1  #g/ml  pepstatin,  and  10  ~g/ml 
leupeptin) were added to the chase medium, and cell debris was pelleted 
as above. The supernatant was collected and Triton X-100 was added to a 
final concentration of 1.0-1.4%. Both SFV-infected cell lysates and chase 
media were analyzed by precipitation with a rabbit antibody against the SFV 
spike protein, followed by nonreducing SDS-PAGE as previously described 
(17). For VSVqnfected samples, immunoprecipitation was performed using 
a  rabbit antibody against purified VSV,  and samples were reduced and 
alkylated before SDS-PAGE (35). Both SFV and VSV samples were evalu- 
ated by reprecipitation to ensure completeness of the immunoprecipitation 
reaction. 
Densitometry was performed on linear exposures of  gels using a Molecu- 
lar  Dynamics Class A  Computing  Densitometer (Sunnyvale,  CA)  with 
Quantity One software from PDI Corp. (Huntington Station, NY). Quanti- 
tation of SFV and sr__f-1 release was expressed as the amount of spike pro- 
teins (El and E2) in the medium divided by the total amount of spike pro- 
teins in the cell lysate plus medium samples. VSV release was quantitated 
by following the amount of the viral M  protein released in the medium 
divided by the total M in cell lysate plus medium. M protein was quantitated 
since the amount of G protein expressed in mosquito cells is reduced (10), 
and a protein migrating close to the position of N protein was secreted from 
uninfected cells (Marquardt, M., unpublished observations). Similar VSV 
release was also observed if radiolabeled virus was pelleted through a su- 
crose cushion and quantitated by SDS-PAGE (data not shown). 
Electron Microscopy 
Control cells were infected as above with wt  SFV  at  10 pfu/cell,  and 
depleted cells with wt SFV at 100-2,000 pfu/cell. Control cells were in- 
fected with sr__f-1 at a multiplicity of 10 infectious centers/cell, and depleted 
cells with 100 infectious centers/cell. After removal of the inoculum, the 
medium was changed twice at 1-2-h intervals to wash off non-endocytosed 
input virus. After a 20-h incubation, cells were fixed in 2.5% glutaralde- 
hyde/0.1 M cacodylate for 30 min, washed inO.1 M cacodylate buffer, osmi- 
cated, dehydrated, and embedded in LX112 (Ladd Research, Burlington, 
VT). Thin sections were stained with uranyl acetate and lead citrate, and 
examined in a JEOL 1200EX (Peabody, MA). 
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Cholesterol-depleted  cells  were  infected  with  200  pfu  wt  SFV/cell  as 
described  above,  and put  into  repleting  medium at  13-h postinfection. 
Repleting medium consisted of LDL-minus growth medium to which a 
stock solution of cholesterol in ethanol was added at a final concentration 
of 50 ttg/ml (this method was a personal communication from Dr. Richard 
Pagano). A parallel plate of depleted cells was put into LDL-minus medium 
without addition of cholesterol. At various times after repletion, cells were 
pulse labeled with [35S]methionine, chased for 90 min, and the cells and 
medium analyzed for SFV expression by immunoprecipitation as described 
above. 
Results 
Infection and Transfection ofC6/36 Cells 
To assess the potential involvement of cholesterol in the post- 
fusion SFV replication cycle, the SFV genome had to be ex- 
pressed in cholesterol-depleted cells. SFV is not capable of 
efficiently infecting cholesterol-depleted cells due to a block 
in fusion with the endosome membrane (35). The difference 
in infectability of the two cell types could be quantitated 
using a  sensitive infectious center assay (Fig.  1 A).  Cells 
maintained in the presence of cholesterol were consistently 
infected  '~2,000  times  more  efficiently than  cholesterol- 
depleted  cells.  If depleted  cells  were  returned  to  LDL- 
containing medium, they gradually regained their ability to 
be infected by SFV (data not shown), suggesting that virus- 
endosome fusion is dependent on the amount of cholesterol 
in the host membrane. 
Since  the  cholesterol-depleted  C6/36  cells  were  not 
efficiently infected by SFV, alternative approaches were re- 
quired to express the SFV genome. One method to circum- 
vent the fusion block was to transfect the cells using lipofec- 
tin and purified SFV RNA.  After  1 h,  the lipofectin was 
removed, the cells were cultured 6 h, and virus-expressing 
cells were quantitated by immunofluorescence with an anti- 
body against the SFV spike. At this time point, the number 
of primary transfected cells could be quantitated in the ab- 
sence of secondary infection. In contrast to the '~2,000-fold 
difference in infection efficiency of the two cell types (Fig. 
1 A), RNA transfection was approximately the same in the 
two cell types (Fig. 1 B). Thus, RNA transfection of  depleted 
cells circumvented the fusion block and delivered SFV RNA 
into the cytoplasm where it was translated. 
Our  second  approach  to  infecting  cholesterol-depleted 
cells took into account the large decrease in infectability in 
the absence of cholesterol. High multiplicities of SFV were 
prebound to depleted cells on ice, and then warmed to 28°C. 
The prebinding step appeared to maximize virus uptake by 
both control and depleted C6/36 cells (Marquardt, M., un- 
published results),  and in combination with the increased 
multiplicity allowed a low level of infection to occur under 
cholesterol-depleted conditions. Although the mechanism of 
SFV entry into the cell in the absence of cholesterol was not 
determined,  infection  was  blocked  by  the  addition  of 
NI-LCI during virus uptake (data not shown).  This result 
suggests that infection of depleted cells occurred by endocy- 
tosis and either low pH-triggered fusion or low pH-depen- 
dent degradation of virus in lysosomes. 
Kinetics of SFV Exit in Control and 
Cholesterol-depleted  C6/36 Cells 
Our results indicated that in the absence of cholesterol the 
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Figure 1. Effect of  cholesterol depletion on SFV infection and trans- 
fection. (A) Infection. Control and depleted cells were infected by 
binding with serial dilutions of  SFV for I h on ice, warming to 28°C 
for 2 h in Opti-MEM/BSA, followed by overnight incubation in 
Opti-MEM/BSA containing 15 mM NI-I4C1  to block secondary in- 
fection. The number of infectious centers was quantitated by im- 
munofluorescence, and normalized to an initial inoculum of one in- 
fectious  center/cell.  Average and  standard  deviation  of eight 
experiments. (B) Transfection. Control and depleted cells were 
transfected with 1/~g SFV RNA and 6 #g lipofectin. After incuba- 
tion for 6 h at 28°C, the infectious centers in 10 random fields of 
each cell type were quantitated by immunofluorescence. Expres- 
sion was normalized to the highest expressing cell type in each ex- 
periment.  Average and standard deviation of three experiments. 
incoming viral  RNA  was  translated to yield a  functional 
membrane-bound RNA polymerase. As qualitatively evalu- 
ated by immunofluoresence, cells that became infected had 
similar levels of viral spike protein expression in the pres- 
ence or absence of sterol (data not shown).  Spike protein 
transport and assembly into virus was then assayed for possi- 
ble cholesterol-dependence. Cells were infected at high mul- 
tiplicity, incubated overnight, and pulsed with [35S]methio- 
nine  to  label  virus  proteins.  The  cells  were  chased  for 
sufficient time to permit transport of the viral spike protein, 
budding,  and release of progeny virions.  Cells and media 
were assayed at the indicated times for the presence of the 
viral spike polypeptides by immunoprecipitation. Both the 
virus inoculum and the amount of label were increased for 
the depleted cell samples to compensate for their decreased 
infectability (see legend to Fig.  2). 
Both control and depleted cells expressed immunoprecip- 
itable spike protein (Fig. 2). The E2 and E3 spike subunits 
are synthesized as a p62 precursor that is posttranslationally 
cleaved (5). The kinetics of this cleavage were the same in 
control and depleted cells. Although these initial steps in vi- 
rus biosynthesis were unaltered, the release of radiolabeled 
virus from the cell was drastically affected by the absence of 
cholesterol. Significant amounts of release from the control 
C6/36 cells were observed after 90-120 min of chase (Fig. 
2 A), and the release at 4 h represented "~21% of the total 
E1 and E2 by densitometry. In contrast, virtually no release 
was observed from depleted cells after 4 h of chase (Fig. 2 
B) (undetectable by densitometry). Some virus appeared to 
be released after 12-24-h chase times, but the proportion of 
spike proteins released from depleted cells was consistantly 
less than that of control cells, even after a 72-h chase (data 
not shown). 
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C6/36 cells. Control  and sterol-depleted cells were infected with 
SFV at multiplicities of 10 and 100 pfu/cell, respectively. After an 
overnight  incubation  cells  were  pulse  labeled  for  15  rnin  with 
[35S]methionine at concentrations  of 50  #Ci/ml for control  and 
200  ttCi/ml  for depleted  ceils.  Cells  were  chased  for various 
periods of time, the chase media were collected, and the cells were 
lysed. Cells and media were incubated with an antibody against the 
SFV spike protein,  and immunoprecipitates  were analyzed using 
SDS-PAGE and autoradiography. Shown is a representative exam- 
ple of seven experiments. 
It was possible that virus was released in the absence of 
cholesterol, but in a form not recognized by our polyclonal 
antibody. The media from a 4 h chase were therefore assayed 
by precipitation  with  "[CA,  rather than  immunoprecipita- 
tion. Large amounts of radiolabeled virus were precipitated 
from control but not depleted cell medium (data not shown). 
The experiment shown in Fig. 2 used high-multiplicity infec- 
tion of depleted cells, but similar results were obtained by 
the RNA transfection method (data not shown). 
We also assayed the production of infectious virus by con- 
trol and depleted cells transfected with virus RNA.  Cells 
were incubated for 6 h after transfection, and the medium as- 
sayed by plaque assay. At this time point, primary transfec- 
tants were strongly positive but the infection had not spread 
to adjacent cells. As shown in Table I, the amount of infec- 
tious SFV released from cholesterol-depleted cells at 6 h was 
consistently 3-4 % of the amount released from control cells. 
Table L  Production  of Infectious  SFV by Control and 
Cholesterol-depleted  Cells 
Experiment  Percent 
number  Cell type  pfu/ml  control 
1  control  1,640  100 
depleted  64  4 
2  control  186  100 
depleted  6  3 
3  control  1,100  100 
depleted  38  4 
35 mm  dishes of (26/36 cells  were  transfected  with 1  t~g SFV RNA using lipofectin 
as described. 6-h posttransfection,  the media were harvested and treated with 
100 ttg/ml RNAse for 30 rain at 370C. Infectious  virus was then quantitated 
by plaque titration on BHK cells. 
Figure  3.  Surface  expression  of  spike  protein  subunits  in 
cholesterol-depleted  cells.  Cholesterol-depleted  C6/36 cells were 
transfected  with  SFV  RNA,  cultured  overnight,  and  fixed with 
paraformaldehyde under nonpermeabilizing conditions. Cells were 
stained with either mAb El-1 against the E1 subunit (A) or mAb 
E2-1 against the E2 subunit (B), followed by rhodamine-labeled 
second antibody. Bar,  10/~m. 
A similar difference between control and depleted ceils was 
observed  8  h  after  transfection  (data  not  shown).  These 
results are in agreement with the difference in virus release 
observed  in  the  pulse-chase  experiments,  although  any 
noninfectious  virus  released  from either  cell  type  is  not 
quantitated by the plaque-assay analysis. 
The delivery of the E1 and E2 spike protein subunits to the 
plasma membrane of control and depleted cells was assayed 
by immunofluorescence with previously characterized sub- 
unit-specific mAbs (17). After RNA transfection, both spike 
protein subunits were expressed on the plasma membrane of 
control or depleted cells,  as  shown in Fig.  3  for depleted 
cells. This experiment indicates that the inhibition of virus 
exit in cholesterol-depleted cells is not due to the failure of 
the spike protein to be transported to the plasma membrane. 
Kinetics of Exit of a Cholesterol-independent 
SFV Mutant 
Although  these  results  suggested  an  effect of cholesterol 
depletion on the exit pathway of SFV,  it was important to 
control for any nonspecific effects of cholesterol depletion on 
the secretory pathway in C6/36 ceils. Pulse-chase studies of 
endogenous  protein  secretion  from  control  and  depleted 
cells suggested that the overall kinetics of secretion in the two 
cell types were similar (data not  shown).  To address this 
question  more quantitatively,  we  took advantage of srf-1, 
an SFV mutant recently isolated in our laboratory (Phalen, 
T., M. T. Marquardt, and M. Kielian, manuscript in prepa- 
ration). This mutant was isolated by selecting for growth on 
C6/36 cells without cholesterol, and showed about 50-fold 
more efficient fusion  with  cholesterol-depleted cell  mem- 
branes than that of wild type SFV. We reasoned that if cho- 
lesterol was playing a virus-specific role in SFV exit, a virus 
that does not require cholesterol for entry into the cell by fu- 
sion might also be independent of cholesterol during exit. 
The results in Fig.  4  show that under  conditions  of iden- 
tical  multiplicity  and  labeling,  srf-1  produced  similar 
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C6/36 cells. Control and cholesterol-depleted cells were infected 
with srf-1 at a multiplicity of 10 infectious centers per cell. Cells 
were incubated overnight, pulse labeled with [3SS]methionine  at a 
concentration of 100 #Ci/ml,  chased for the indicated times, and 
the cells and media assayed for labeled spike proteins by immuno- 
precipitation followed by SDS-PAGE  and autoradiography. Shown 
is a representative example of four experiments. 
amounts of spike protein in control and depleted cells (Fig. 
4).  The kinetics of srf-1  p62 processing were also similar 
in  the  two cell types.  Finally,  and  in  marked contrast to 
results with wt SFV (Fig. 2), the kinetics of sr___f-1 exit from 
depleted cells were found to be equivalent or faster than 
those in control cells (Fig. 4). The release of srf-1 at 3 h was 
6% from control cells and 24% from depleted cells by den- 
sitometry (average of two experiments). Similar cholesterol- 
independent release was observed with two other sr__f  mu- 
tants, and will be described in detail elsewhere (Phalen, T., 
M.  T.  Marquardt, and M.  Kielian, manuscript in prepara- 
tion). These results suggest that the secretory pathway per 
se is unaffected by cholesterol depletion, and that the sterol 
requirement is specific for a step in the SFV exit pathway. 
Effect of Cholesterol Depletion on the Assembly and 
Release of VSV 
As  a  second control for the  specificity of the cholesterol 
effect, we assayed the exit of VSV, an unrelated rhabdovirus. 
VSV also infects cells by endocytosis and low pH-mediated 
fusion, but its fusion activity is cholesterol independent (6, 
35). VSV-infected control and depleted cells showed similar 
expression of  virus proteins, as quantitated by following syn- 
thesis of the VSV M protein (Fig. 5, cell samples).  In con- 
trast to results with wt SFV, release of VSV from control and 
depleted cells was comparable (Fig.  5,  medium  samples). 
After a  3-h chase period,  M  protein release ranged from 
13-28%  of the total from control cells, and from 13-22% 
of the total from depleted cells (quantitation from two ex- 
periments). These results in C6/36 cells are in contrast to the 
tenfold reduction in VSV production previously reported in 
a  cholesterol-depleted manunalian  cell  line  (32),  which 
could reflect the deleterious effects of cholesterol depletion 
in  mammalian  cells.  Taken together,  our results  with  w__tt 
SFV, srf-1, and VSV suggest that the cholesterol requirement 
for virus exit was specific for viruses requiring cholesterol 
for entry into the cell by membrane fusion. 
Figure 5. Kinetics of VSV exit in control and cholesterol-depleted 
C6/36 cells. Control and depleted cells were infected with VSV at 
200 pfu/cell, incubated overnight, pulse labeled with [35S]methio- 
nine at a concentration of  50 #Ci/ml, chased for  the indicated times, 
and the cells and media assayed for labeled virus proteins by immu- 
noprecipitation with an antibody against purified VSV, followed  by 
SDS-PAGE  and autoradiography. The M protein precipitation from 
a representative example of two experiments is shown. 
Electron Microscopy of  SFV-infected Cells 
In addition to the biochemical assays for virus production, 
ultrastructural analysis was used to visualize virus produc- 
tion in infected C6/36 cells. The normal mode of alphavirus 
release from mammalian cells is by budding from the plasma 
membrane (39). The mechanism of release from mosquito 
cells may involve both plasma  membrane budding and/or 
packaging into cytoplasmic vesicles that release virus upon 
exocytosis (2, 43). Depending on the mosquito cell line used 
for virus  infection,  either mode of virus maturation may 
predominate (26). To examine budding of SFV in control and 
depleted cells, EM was performed after infection with wt or 
srf-1  SFV.  Parallel cultures were assayed for infection by 
immunofluorescence. In control cells infected with wt virus, 
abundant virion formation was observed at the plasma mem- 
brane,  and few cytoplasmic inclusions of virus were seen 
(Fig. 6 A). In contrast, neither plasma membrane nor intra- 
cellular  virion  formation  was  observed  in  cholesterol- 
depleted cells (Fig.  6  B).  We were also unable to detect 
significant numbers of assembled nucleocapsids or nascent 
virus buds in the cholesterol-depleted cells. Virus particles 
were not observed in the depleted cells even after infection 
with 2,000 pfu/cell. Importantly, EM of cells infected with 
the sr__f-1 mutant revealed large numbers of morphologically 
normal virions that appeared to be budding from the plasma 
membrane of both control and depleted cells (Fig. 7, A and 
B). Thus, the EM experiments corroborated the biochemical 
assays of both SFV and sr__f-1 exit. 
Reversal of the Exit Block by Sterol Addition 
The reversibility of  the exit block was assayed by the addition 
of cholesterol to the culture medium of previously infected 
depleted cells.  The amount of cholesterol added  (50 /~g) 
represents approximately a 30-fold excess over the amount 
of cholesterol found in  the  same  number of nondepleted 
C6/36  cells  (35).  The  release  of virus  was  followed by 
pulse-chase analysis at various times after cholesterol addi- 
tion. Reversal of  the exit block was observed 9 h after choles- 
terol repletion (Fig. 8), at which time densitometry showed 
that •14%  of the total spike proteins were released into the 
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SFV-infected  control  and  sterol- 
depleted  C6/36 cells.  Cells were  in- 
fected  with wt SFV  at  multiplicities 
of  10  pfu/control  cell  (A)  or  100 
pfu/depleted cell (B). After *20 h of 
culture,  the  cells  were  fixed  and 
processed for transmission EM. Bar, 
0.5 #m. 
Figure  7. Electron micrographs of srf- 
1-infected control and sterol-depleted 
C6/36  cells.  Control  or  sterol- 
depleted cells were infected with sff-1 
at a multiplicity of 10 infectious cen- 
ters/cholesterol-containing  cell  (A), 
and  100  infectious  centers/depleted 
cell (B).  After •20  h  of culture, the 
cells  were  fixed  and  processed  for 
transmission EM. Bar, 0.5 #m. 
The Jourllal of Cell Biology, Volume 123, 1993  62 Figure 8.  Effect of cholesterol  addition on the SFV exit block. 
Depleted cells were infected with wt SFV at a multiplicity of 200 
pfu/cell, and incubated for 13 h at 28"C. The cells were then ex- 
posed to 50 #g cholesterol in I ml for 9-20 h, and SFV exit assayed 
by a 30 min label with 20/zCi [35S]methionine/ml, followed by a 
90-min chase. As a control, depleted cells were incubated without 
the addition of cholesterol for 20 h (time 0). Cells and media were 
assayed for virus release by immunoprecipitation. Shown is a repre- 
sentative example of four experiments. The time 0 lanes were ex- 
posed about  fivefold longer to normalize for protein expression 
levels. 
medium after a 90-min chase. The level of release did not 
change after as much as 20 h of cholesterol repletion. This 
amount of virus production is comparable or higher than that 
obtained from control cells after a 90-min chase (Fig. 2). No 
reversal of the exit block was observed after only 4 h of cho- 
lesterol repletion (data not shown). 
We also wished to determine if virus structural proteins 
synthesized in the absence of cholesterol were able to re- 
cover their exit competence. Infected depleted cells were 
pulse labeled, cholesterol was added to the chase medium, 
and the medium assayed for released radiolabeled virus after 
various times of chase. Little release was observed even after 
12 h of chase (data not shown). This result is difficult to in- 
terpret, however, as there was substantial turnover of the la- 
beled spike proteins during the repletion and chase period. 
Discussion 
Using cholesterol-depleted mosquito cells, we have identi- 
fied a requirement for cholesterol in the exit pathway of wt 
SFV.  No cholesterol requirement was observed for the exit 
of srf-1, an SFV cholesterol-independent fusion mutant, or 
for the rhabdovirus VSV. Cholesterol is thus important both 
in  SFV-endosome fusion (35) and in  SFV exit.  Since the 
mosquito is the natural vector for alphaviruses, the availabil- 
ity of cholesterol in the insect would be predicted to affect 
these two aspects of the SFV infection cycle. Studies have 
shown that the distribution of cholesterol varies among in- 
sect tissues (3), and this distribution might therefore affect 
their  ability  to  support  primary  SFV  infection  or  virus 
production. 
Cholesterol was able to reverse the block in the virus exit 
pathway by 9 h after sterol addition. These kinetics are some- 
what slower than reversal of the block in SFV-endosome fu- 
sion,  which showed reversal 5 h  after cholesterol addition 
(35). It is not clear if this reflects simply the differences in 
assay sensitivities and experimental protocols, or a true re- 
quirement for a higher cholesterol level in exit versus fusion. 
The slower reversal of the exit block might also reflect the 
time needed for the de novo synthesis of a component, or the 
turnover of a virus protein synthesized in the absence of cho- 
lesterol. 
The intriguing question prompted by the studies in this re- 
port is the mechanism of cholesterol's effect on virus exit. To 
consider possible explanations, we will review the events in- 
volved in the SFV life cycle (39, 41, 44). After virus-endo- 
some fusion, the nucleocapsid is released into the cytoplasm 
and the genomic RNA is translated to give the four subunits 
of the viral replication complex. This replicase synthesizes 
a minus-strand copy of the genomic RNA that serves as a 
template for both full-length plus-strand RNA, and the sub- 
genomic RNA encoding the structural proteins. These reac- 
tions occur on membranes that appear to be derived from 
lysosomes  and  endosomes  (7).  The  subgenomic  RNA  is 
translated to give the cytoplasmic capsid protein,  and the 
p62, 6K, and E1 membrane-bound polypeptides. The capsid 
protein packages the full-length RNA to form the virus nu- 
cleocapsid. The spike proteins are transported as a complex 
of El, p62, and 6K through the RER and Golgi compart- 
ments (23, 47), and the p62 precursor is cleaved to mature 
E2 and E3 (5). The mature spike proteins are transported to 
the plasma membrane, where they form patches that exclude 
host cell proteins (33). The nucleocapsid then interacts with 
the 31-residue-long cytoplasmic tail of E2 to drive the bud- 
ding of  virus (14, 45). The virus particle is released by a final 
pinching off  and fission of the plasma membrane to close the 
virus envelope. 
Our studies suggested that depleted ceils expressing the 
SFV genome could translate the SFV genomic RNA, produce 
a functional RNA polymerase, make subgenomic RNA, syn- 
thesize the structural proteins, and transport the spike pro- 
tein to the plasma membrane. In the absence of cholesterol, 
however, these spike proteins were not efficiently released in 
virus particles. The inhibition of virus exit could be due to 
a block in full-length RNA production, to a decreased rate 
of spike protein transport to the plasma membrane,  or to 
defects in virus subunit interactions, virus assembly, or the 
final budding reaction that releases the completed virus par- 
ticle. 
It seems likely that the full-length plus-strand RNA is pro- 
duced, since analysis of RNA- Sindbis ts mutants suggests 
that if the polymerase can initiate from the subgenomic pro- 
motor, it can also produce full-length RNA (12). 
A number of spike subunit and capsid interactions are re- 
quired for viral protein transport,  assembly,  and budding 
(39). E1 and p62/E2 dimerize before leaving the RER, and 
are found as a tightly associated dimer during transport and 
in virus particles. Our preliminary results suggest that the 
spike subunits from either control or depleted cells dimerize 
equivalently (data not shown).  There has been some con- 
troversy  concerning  the  localization  of p62  cleavage  in 
mosquito cells, with the suggestion that cleavage might occur 
in the RER in this cell type (27). However, we have observed 
that cleavage is blocked by treating C6/36 cells with either 
carbonylcyanide  m-chlorophenylhydrazone  or  monensin, 
agents that block protein transit beyond the RER or medial- 
Golgi,  respectively (data  not shown).  It is therefore most 
likely that p62 cleavage in C6/36 cells occurs in the TGN or 
immediately thereafter, as has been shown in mammalian 
cells (5).  The apparently normal p62  cleavage kinetics in 
depleted cells (Fig.  2) therefore implies that spike protein 
traffic to the TGN was unaffected by sterol. Immunofluores- 
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to the plasma membrane in cholesterol-depleted ceils (Fig. 
3).  Although the  detailed kinetics  of plasma  membrane 
transport have not yet been evaluated, it appears unlikely that 
a markedly slower transport rate is responsible for decreased 
virus release in the absence of cholesterol. 
The spike protein assembles into a trimer (E1-E2-E3)3 on 
the surface of  virus-infected cells (36) or virus particles (46), 
and it is possible that this trimeric interaction requires cho- 
lesterol. The block could also lie in the formation of nucleo- 
capsids or their interaction with the cytoplasmic tail of E2. 
Recent studies have suggested a potential role of the small 
hydrophobic 6K polypeptide in alphavirus exit. Newly syn- 
thesized 6K appears to associate with the E1 and E2 subunits 
during transport (23), and is incorporated into virus parti- 
cles at a 10-fold lower stoichiometry  than the other structural 
proteins (9). Using a 6K deletion mutation of an SFV infec- 
tious clone, a block in virus release was observed for virus 
lacking the 6K polypeptide (21). In cells infected with this 
mutant, spike proteins are synthesized and p62  is cleaved 
normally, but release of labeled or infectious virus is greatly 
decreased.  6K is fatty acylated on cysteine residues in or 
near its putative transmembrane domain (9, 20). Alteration 
of these cysteines by site-directed mutagenesis of the Sindbis 
virus infectious clone resulted in underacylated 6K, and also 
conferred a budding defect on the progeny virions (8).  Un- 
like the block  in virus  production caused by cholesterol 
depletion, the acylation mutants produce aberrant particles 
with multiple nucleocapsids. Taken together, these data sug- 
gest that it is important to determine if the exit block in 
cholesterol-depleted cells involves effects on 6K. 
Our EM data to date have not shown a definitive location 
for the block in SFV exit, but suggest that the block in virus 
release may lie in a virus assembly step.  The limitations in 
interpreting these results are that immunofluorescence as- 
says show that only about 15% of the depleted cells are ex- 
pressing SFV, and that EM alone does not differentiate be- 
tweeen infected and uninfected cells. Immuno-EM should 
prove useful to positively identify infected cells and to local- 
ize the  spike  and capsid proteins.  Further ultrastructural 
studies should also reveal if the block is localized to the final 
pinching off of the virus bud to form a completed particle. 
This step involves a membrane fission event, which could be 
mediated by a similar spike protein mechanism as that in- 
volved in the cholesterol-requiring fusion activity of SFV. 
Membrane fusion  joins two membrane-bound compartments 
to form one, while membrane fission divides one membrane 
compartment into two  (42).  Although fusion and fission 
processes appear symmetrical, they may occur via different 
mechanisms (42).  One clear distinction in the SFV system 
is that fusion in the endosome requires low pH, while mem- 
brane fission during virus budding must take place at the 
neutral pH of the cytoplasm. It is interesting that in the srf-1 
mutant, the cholesterol requirements for fusion and for virus 
exit were both overcome. Additional SFV mutants are cur- 
rently being sought in the hope of distinguishing between the 
cholesterol-requiring events in entry and exit. 
The roles of cholesterol in animal cells are largely unex- 
plained. In mammalian cells, cholesterol appears to play a 
crucial role in membrane structure, affecting both perme- 
ability and stability (28, 51). Surprisingly, work with choles- 
terol-depleted cultured insect cells has demonstrated that 
cholesterol is not a required structural component of the in- 
sect cell membrane, and thus the dietary sterol required by 
insects may be needed for hormone production or other fac- 
tors (40). In mammalian cells, cholesterol is highly compart- 
mentalized among cellular membranes, being low in the ER 
and high in the plasma membrane (4,  51). Although it is 
clear that cells expend considerable metabolic energy in es- 
tablishing and maintaining this cholesterol polarity, its cellu- 
lar  function is  completely unknown.  Within mammalian 
cells, there are endogenous proteins that have specific inter- 
actions and requirements for cholesterol, but in no case has 
the molecular basis of such an interaction been defined. For 
example, HMG-CoA reductase, the rate-limiting enzyme of 
cholesterol biosynthesis, is an ER enzyme that is down regu- 
lated by a cholesterol-dependent degradation event (11). Re- 
cent studies have shown that cholesterol is important in the 
maintenance  of  receptor  clustering  for  the  methyltetra- 
hydrofolate receptor (38), due to a cholesterol requirement 
for the structure of caveolae, the specialized membrane do- 
mains  in  which the  folate receptor  is  endocytosed (37). 
Thus, even the limited amount of data currently available 
suggests that cholesterol plays a variety of important roles in 
the function of mammalian cells. Perhaps studies in progress 
in our laboratory on the mechanism of the cholesterol re- 
quirement for SFV fusion and exit will also be able to ad- 
dress more general questions about the differences between 
the mammalian and insect cell cholesterol requirements, and 
the functions of cholesterol in animal cells. The unexpected 
finding of an involvement of cholesterol in SFV exit suggests 
that future studies of the role of lipids in viral and cellular 
function may uncover additional new roles for these little un- 
derstood constituents. 
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